Antifungals will lead ringworm treatment sales through 2036 with 48.9% of the drug class segment in 2026. Topical treatments lead the route of administration segment with a 63.7% share. The market is projected to reach USD 9.7 billion in 2026 and USD 15.53 billion by 2036, creating an incremental opportunity of USD 5.81 billion.